Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-21

FDA Approved: DOBUTAMINE — Original Application (Slate Run Pharmaceuticals)

View source ↗

Summary

FDA approves Slate Run Pharmaceuticals' dobutamine—Original Application (ANDA 216131)—granting approval of a generic dobutamine product. This action expands acc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dobutamine (dobutamine)

Snippet

ORIG AP for DOBUTAMINE (DOBUTAMINE)